Related Experiment Video

Updated: Jun 16, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.0K

The pressing need for imaging biomarkers of disability progression in multiple sclerosis

Pablo Naval-Baudin1,2,3,4, Pablo Arroyo-Pereiro5,6,7, Carles Majós8,9,10

  • 1Radiology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Carrer de Feixa Llarga SN, 08907, Barcelona, Spain. pablo.naval.idi@gencat.cat.

European Radiology
|November 24, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.1K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.0K

Related Experiment Videos

Last Updated: Jun 16, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.0K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.1K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.0K

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Articles linked to this work by shared authors, journal, and citation graph.

Serum biomarkers remain stable after transitioning from intravenous to subcutaneous natalizumab in multiple sclerosis.

Journal of neurology·2026

Radiotherapy for intramedullary, leptomeningeal and epidural metastases: outcomes of an unusual and ominous complication.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026

Benign multiple sclerosis and long-term outcomes after 30 years.

Journal of neurology·2025

3D T1 turbo spin echo improves detection of gadolinium-enhancing multiple-sclerosis lesions.

Insights into imaging·2025

Machine Learning Analysis of Single-Voxel Proton MR Spectroscopy for Differentiating Solitary Fibrous Tumors and Meningiomas.

NMR in biomedicine·2025

Post-contrast Susceptibility Weighted Imaging in Multiple Sclerosis MRI Improves the Detection of Enhancing Lesions.

Clinical neuroradiology·2025

Identifying optimal dose head CT acquisition techniques through cluster analysis from 904,209 scans.

European radiology·2026

From digital bench to bedside: exaggerated risks, realistic expectations, and genuine challenges of medical AI.

European radiology·2026

Improving diagnostic performance of O-RADS MRI: semi-quantitative intensity curves vs visual assessment of enhancement.

European radiology·2026

Automated artificial intelligence performance for longitudinal pulmonary nodule matching in lung cancer screening.

European radiology·2026

Uncovering underdiagnosed emphysema: comparative assessment using clinical CT and micro-CT.

European radiology·2026

Photon-counting detector CT for CT pulmonary angiography: a systematic review and meta-analysis.

European radiology·2026

Unexpected Conduction Blocks in SORD-Related Distal Motor Neuropathy: A Case Report.

Clinical case reports·2026

Serum Uric Acid in Chronic Kidney Disease as a Marker of Risk or a Modifiable Driver of Progression: A Systematic Review.

Cureus·2026

Immunomodulatory and anti-inflammatory potential of S-nitrosoglutathione (GSNO) in multiple sclerosis: a review of mechanisms and therapeutic perspectives.

Frontiers in immunology·2026

Systematic review of unveiling the potential of AI using machine learning and deep learning methods in neurodegenerative diseases.

PeerJ. Computer science·2026

Amyotrophic lateral sclerosis -plus patient with an intermediate-length CACNA1A allele: a Case Report.

Frontiers in genetics·2026

Silent neurovestibular frailty: a conceptual model integrating vestibular dysfunction, dual-task mobility and cognitive load as candidate contributors to falls, delirium and functional decline in older adults.

Frontiers in aging neuroscience·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us